Evaluation of some Virulence Factors and Drug Resistance of Bacteria Isolated from the Urine of Patients with TCC-Bladder Cancer
Main Article Content
Abstract
Urinary tract infections (UTIs) mean microbial pathogens in the urethra or bladder (lower urinary tract). Important risk factors for recurrent UTI include obstruction of the urinary tract, use of a bladder catheter or a suppressed immune system. This study aims to isolate and identify bacteria from patients with TCC-bladder cancer or patients with a negative cystoscope and estimate antibiotic susceptibility patterns and evaluate some of the virulence factors. From a total of 62 patients with TCC-BC or negative cystoscope, only 35 favorable bacterial growths were obtained, including Escherichia coli (UPEC), a significant bacterial isolate, and Stenotrophomonas maltophilia. The percentage of multi drug-resistance bacteria (MDR) was identified in (62.8%) while the extended drug-resistance bacteria (XDR) was (28.5%). All isolates were producer for biofilm either moderately 18/35 (49%) or strongly 18/35 (51%). Only 25/35 (71%) isolates were produced for siderophore, while 10/35 (29%) isolates were non-produced. Inducing cytochrome P450 expression protein was seen in (14/35) 40% isolates. In conclusion, patients with TCC-BC or negative cystoscope who had a urinary catheter or immune-compromised were at high risk of infecting with nosocomial or opportunistic pathogens, which could be develop antibiotic resistance, the central problem in the cohort of patients undergoing chemotherapy or immune cancer therapy
Received 17/11/2020, Accepted 3/3/2021, Published Online First 20/11/2021
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
Salvatore S, Salvatore S, Cattoni E, Siesto G, Serati M, Sorice P, et al. Urinary tract infections in women. Eur J Obstet Gynecol Reprod Biol. 2011 Jun;156(2):131-6
Vermeulen SH, Hanum N, Grotenhuis A J, Castan G, Vinyals O, Heijden AG, et al Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study. Br J Cancer. 2015 Feb;112(3):594-600.
Robino L, Gonzalez MJ, Radio G, Gomez V, Scavone P. Fosfomycin trometamol activity on biofilm and intracellular bacterial communities produced by Uropathogenic E. coli isolated from patients with Urinary tract infection. IJID.2018Aug;73(142): 3–398.
Delcaru C, Alexandru I, Podgoreanu P, Grosu M, Elisabeth S, Mariana C, et al. Microbial Biofilms in Urinary Tract Infections and Prostatitis: Etiology, Pathogenicity, and Combating strategies. Pathogens. 2016 Nov;5(4):65.
Ainsworth C. Microbiome: a bag of surprises. Nature. 2017 Nov;551(7679):S40-1.
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. CLSI supplement M100. 2017.
Johnson JR, Stell AL. Extended Virulence Genotypes of Escherichia coli Strains from Patients with Urosepsis in Relation to Phylogeny and Host Compromise. J Infect Dis. 2000 Jan;181(1):261-72.
Titik N. Current in vitro assay to determine bacterial biofilm formation of clinical isolates. J Med Sci.2014 Sep; 46(3): 142-152
Karen E, Roger B. Media Preparation and Bacteriological Tools. New York. Wiley:2002[cited 01 August 2002]1.0.1-A1.K.26p.https://doi.org/10.1002/0471142727.mb0101s59
Ikatsu H, Kino Y, Kawahra N, Adachi M, Miyoshi S, Tomochika K, et al. Isolation and Characterization of Cytochrome P450-Producing Bacteria from Various Environments. Biocontrol Sci. 2000 Apr ;5(2): 111-116.
Naveen KA, Maya V.Modified microplate method for rapid and efficient estimation of siderophore produced by bacteria. 3 Biotech. 2017 Dec;7(6):381.
Kalidasan V, Adleen A, Narcisse J, Suresh K, Rukman AH, Vasantha KN. Will Go to War for Iron: Stenotrophomonas maltophilia Strategy. Molecules. 2018 Aug;23(8):2048.
Ahmed E, Mohamed A, Romaila R, Mahmoud M Z, Bedeir A. Effect of pathogenic bacteria on reliability of CK-19, CK-20 and UPII as bladder cancer genetic markers: A molecular biology study, Egypt. j. basic appl. sci. 2015 Sep; 2(3): 176-182.
Adris P, Estraño C, Chung KT. The metabolic activation of 2-aminofluorine, 4-aminobiphenyl, and benzidine by cytochrome P-450-107S1 of Pseudomonas aeruginosa. Toxicol In Vitro. 2007 Dec;21(8):1663-71.
El-Mosalamy H, Salman TM, Ashmawey AM, Osama N. Role of chronic E. coli infection in the process of bladder canceran experimental study. Infect Agent Cancer. 2012 Aug;7(1):19.
Guoqin M, Limei C, Ran L, Quan L, Haoran Z, Yingfei M. Common Core Bacterial Biomarkers of Bladder Cancer Based on Multiple Datasets. BioMed Research International. 2019 May; 8 :1-8.
Abiye T, Worku F, Gizeaddis B, Baye G. Prevalence of Asymptomatic Bacteriuria and Antibiotic Susceptibility Patterns of Bacterial Isolates among Cancer Patients and Healthy Blood Donors at the University of Gondar Specialized Hospital. Hindawi Int. J. Microbiol. 2020 Mar;9
Ohshima H, Tatemichi M, Sawa T. Chemical basis of inflammation-induced carcinogenesis. Arch Biochem Biophys. 2003 Sep;417(1):3-11
Polse RF, Yousif SY, Assafi MS. Prevalence and antimicrobial susceptibility patterns of uropathogenic E. coli among people in Zakho, Iraq. Int J Res Med Sci. 2016Apr; 4(4):1219-1223.
Mohammad K, Ahmed Z, Mohammed B, Saeed R. Determination the site of antibiotic resistance genes in Escherichia coli isolated From Urinary Tract Infection. KJA R. 2018 Oct; 3(2): 6-12.
Raeispour M, Ranjbar R. Antibiotic resistance, virulence factors and genotyping of Uropathogenic Escherichia coli strains. Antimicrob Resist Infect Control . 2018 Oct ;7:118.
Flores-Treviño S, Gutiérrez-Ferman JL, Morfín-Otero R, Rodríguez-Noriega E, Estrada-Rivadeneyra D, Rivas-Morales C, et al. Stenotrophomonas maltophilia in Mexico: antimicrobial resistance, biofilm formation and clonal diversity. J Med Microbiol. 2014 Nov; 63(11):1524-1530.
Çıkman A, Parlak M, Bayram Y, Güdücüoğlu H, Berktaş M. Antibiotics resistance of Stenotrophomonas maltophilia strains isolated from various clinical specimens. Afri Health Sci. 2016 Mar;16(1): 149-152.
Ma'rio'G, Edit U. Prevalence and Antibiotic Resistance of Stenotrophomonas maltophilia in Respiratory Tract Samples: A 10-Year Epidemiological Snapshot. Health Serv Res Manag Epidemiol. 2019 Aug; 6:2333392819870774.
Ezenobi NO, Ogbu HI, Onosigho I. Antimicrobial susceptibility pattern of urinary isolates from outpatients suspected for urinary tract infection. GSC Biol. Pharm.Sci. 2018 Nov; 5(3): 01-11.
Jan H, Pavel C, Roman Z. Current Antibiotic Resistance Trends of Uropathogens in Central Europe: Survey from a Tertiary Hospital Urology Department 2011–2019. Antibiotics. 2020Jan; 9(9):630.
Nawfal RH, Shameran D, Khoshi S, Mahde SA. Urinary Tract Infections and Antibiotic Sensitivity Patterns Among Women Referred to Azadi Teaching Hospital, Duhok, Iraq. vicenna J Clin Microbiol Infect. 2018 Dec;5(2): 27-30.
Tewari R, Chopra D, Wazahat R, Dhingra S, Dudeja M. Antimicrobial Susceptibility Patterns of an Emerging Multidrug Resistant Nosocomial Pathogen: Acinetobacter baumannii. J Med Sci. 2018 May; 25(3):129-134
Neha R, Purva M. Ochrobactrum anthropi: An emerging pathogen causing meningitis with sepsis in a neurotrauma patient. J Infect Dev Ctries. 2017 Sep;11(9):733-735.
Nimri L, Sulaiman M, Hani OB. Community-acquired urinary tract infections caused by Burkholderia cepacia complex in patients with no underlying risk factor. JMM Case Rep. 2017Jan ;4(1): 005081
Shukla R, Bilolikar AK, Udayasri B, Pragya R. Antibiotic susceptibility pattern of Burkholderia cepacia complex from various clinical samples in a tertiary care center: A one-year prospective study. J Med Sci Res. 2018Jan; 6(1):1-5.
Lim CTS, Lee SE. A rare case of Ralstonia mannitolilytica infection in an end stage renal patient on maintenance dialysis during municipal water contamination. Pak J Med Sci. 2017Aug;33(4):1047-1049.
Monica B, Carolina V, Giammarco R, Anna SN, Francesco A, Emanuela G, et al. A case of persistent bacteraemia by Ralstonia mannitolilytica and Ralstonia pickettii in an intensive care unit. Infect Drug Resist. 2019 Aug;12: 2391-2395.
Qingqing F, Yu F, Ping F, Xiaohui W, Zhiyong Z. Nosocomial bloodstream infection and the emerging carbapenem-resistant pathogen Ralstonia insidiosa. BMC Infect Dis. 2019Apr; 19:334.
Gupta PK, Appannanavar SB, Kaur H, Gupta V, Mohan B, Taneja N. Hospital acquired urinary tract infection by multidrug-resistant Brevundimonas vesicularis. Indian J Pathol Microbiol. 2014Sep;57(3):486-8
Mohua B, Shiv SC, Kheya M, Sanjeev D, Chinmoy G, Banya C, et al. Enterococcal Urinary Taract Infection: An Emerging Threat. J. Evol. Med. Dent. Sci. 2015Mar; 4(17).
Manshi L, Fuhuo Y, Yihan L, Weifeng H. Identification of Enterococcus faecalis in a patient with urinary-tract infection based on metagenomic next-generation sequencing: a case report. BMC Infect Dis. 2020Jul; (20):467
Ramana VK. A case of urinary tract infection caused by Kocuria species and identified by conventional methods. Perspect Clin Res. 2016Aug; 4(2): 64-66.
Wafaa A, Somaya M, Abeer A, Hasnaa S. Detection of Some Virulence Factors and Pyelonephritis– Associated Pilus (pap) Encoding Operon Gene in Uropathogenic Escherichia coli. Egypt J Med Microbiol. 2015 Jul;24 (3):37-43
Zina MA. Immunonohistochemical Detection of Gram-Positive Bacterial LTA associated with Urinary Tract Infection among Urinary Bladder Cancer patients. J. Nat. Sci. Res. 2015Sep; 20(5):19-25
Noor JO, Maysaa ARD. The Role of Mutation and Gene Expression Level of marRAB operon in Multi Antibiotic Resistance uropathic Escherichia coli and 0157:H7 isolates from patients in Baghdad. J. Pharm. Sci. & Res. 2020Apr; 12(3): 365-374
Masoud R, Ahmad R, Hamid RM, Mehdi RG. Detection of pap, sfa, afa, foc, and fim Adhesin-Encoding Operons in Uropathogenic Escherichia coli Isolates Collected from Patients with Urinary Tract Infection. Jundishapur J Microbiol. 2015 Aug; 8(8).
Khairy RM, Mohamed ES, Abdel Ghany HM, Abdelrahim SS. Phylogenic classification and virulence genes profiles of uropathogenic E. coli and diarrhegenic E. coli strains isolated from community acquired infections. PLoS ONE.2019Sep; 14(9).
Lima JLC, Alves LR, Paz JNP, Rabelo MA, Maciel MAV, Morais MMC. Analysis of biofilm production by clinical isolates of Pseudomonas aeruginosa from patients with ventilator-associated pneumonia. Rev Bras Ter Intensiva.2017 Sep;29(3):310-316.
Roshni AMA, Venkitanarayanan K. Role of Bacterial Biofilms in Catheter-Associted Urinary Tract Infections (CAUTI) and Strategies for Their Control. Vienna. Thomas Nelius: 2013[cited July 10th 2013] 184p.https://www.intechopen.com/books/recent-advances-in-the-field-of-urinary-tract infections/role-of-bacterial-biofilms-in-catheter-associated-urinary-tract-infections-cauti-and strategies-for-
Cristina D, Ionela A, Paulina P, Mirela G, Elisabeth S, Mariana CC, et al. Microbial Biofilms in Urinary Tract Infections and Prostatitis: Etiology, Pathogenicity, and Combating strategies. Pathogens. 2016 Dec; 5(4):65.
Eberly AR, Floyd KA, Beebout C J, Colling S J, Fitzgerald M J, Stratton CW, et al. Biofilm Formation by Uropathogenic Escherichia coli Is Favored under Oxygen Conditions That Mimic the Bladder Environment. Int J Mol Sci. 2017 Sep;18(10):2077
Hojjatolah Z, Ali S. Biofilm formation in uropathogenic Escherichia coli: association with adhesion factor genes. Turk J Med Sci. 2018Feb; 48(1): 162-167.
Karigoudar RM, Karigoudar MH, Wavare SM, Mangalgi SS. Detection of biofilm among uropathogenic Escherichia coli and its correlation with antibiotic resistance pattern. J Lab Physicians. 2019 Jan; 11(1):17-22.
Payam B, Edit U, Márió G. Association between Biofilm-Production and Antibiotic Resistance in Uropathogenic Escherichia coli (UPEC): An In Vitro Study. Diseases. 2020 Jun; 8(2):17.
Maurice NM, Bedi B, Sadikot RT. Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections. Am J Respir Cell Mol Biol. 2018 Apr;58(4):428-439.
Jailton LCL, Paula RLAJ, João PBN, Maria AVM, Marcia MCM. Biofilm production by clinical isolates of Pseudomonas aeruginosa and structural changes in LasR protein of isolates non biofilm-producing. Braz J Infect Dis.2018 Apr;22(2):129-136
AnneS, Messiaen H, NelisTom C. Investigating the role of matrix components in protection of Burkholderia cepacia complex biofilms against tobramycin. J. Cyst. Fibros. 2014Jan; 13(1): 56–62.
Yomna AH, Heba MA, Tamer ME, Aymen SY, Ramy KA. Biofilm formation in enterococci: genotype-phenotype correlations and inhibition by vancomycin. Sci Rep. 2017 Jul 18;7(1):5733
Zheng JX, Bai B, Lin ZW, Pu ZY, Yao WM, Chen Z, et al. Characterization of biofilm formation by Enterococcus faecalis isolates derived from urinary tract infections in China. J Med Microbiol. 2018 Jan;67(1):60-67
Mehvish S, Betty D. Detection of Siderophore production in Uropathogenic Escherichia.coli in patients with Type 2 Diabetes Mellitus. IP Int J Med Microbiol Trop Dis. 2017 Dec;3(4):176-177
Ahmed AJ, Qassim MH. Phenotypic and molecular characterization of some virulence factors in multidrug resistance Escherichia coli isolated from different clinical infections in Iraq. Am. J. Biochem. Mol. Biol.2017 Apr; 7(2): 65-78
García C, Passerini B, Alcaraz E, Vay C, Franco M. Siderophores of Stenotrophomonas maltophilia: detection and determination of their chemical nature. Rev. Argent. Microbiol. 2012; 44: 150-154.
Stavropoulou E, Pircalabioru GG, Bezirtzoglou E. The Role of Cytochromes P450 in Infection. Front. Cell. Infect. Microbiol. 2018Nov; 31(9) 89.
Xiaodong Z, Yaqin P, Jing Z, Qian L, Xiaojuan Y, Carlos G, et al. Bacterial cytochrome P450-catalyzed regioand stereoselective steroid hydroxylation enabled by directed evolution and rational design. Bioresour. Bioprocess. 2020Dec; 7(2):1-18
Halasz A, Manno D, Perreault NN, Sabbadin F, Bruce NC, Hawari J. Biodegradation of RDX nitroso products MNX and TNX by cytochrome P450 XplA. Environ Sci Technol. 2012Jul; 46(13):7245–7251